Merck & Co’s Absci ABSI Stock Holding History

Merck & Co’s Portfolio ABSI Stock Details ABSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-998,163	Closed	-$2.62M	–	13
2024 Q4	$2.62M	Buy	+998,163	New	+$3.51M	1.01%	7

Other funds holding ABSI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Merck & Co's ABSI Position: Q1 2025 in Review

Merck & Co sold out of Absci (ABSI) in Q1 2025, closing a stake of 998,163 shares — an estimated $2.62M sold.

Merck & Co first reported a position in ABSI in Q4 2024 and held it in 1 quarter. The position peaked at $2.62M in Q4 2024. 139 funds tracked by Wall St. Rank hold ABSI as of Q1 2025.

Merck & Co reported no remaining Absci position as of Q1 2025 after selling out during the quarter.
Merck & Co sold 998,163 Absci shares in Q1 2025, an estimated $2.62M.
Merck & Co first reported a position in Absci in Q4 2024 and held it in 1 quarter.
Merck & Co's Absci position peaked at $2.62M in Q4 2024.
139 funds tracked by Wall St. Rank held Absci as of Q1 2025.

Based on Merck & Co's 13F filing for Q1 2025, filed 14 May 2025.